Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide + low-dose dexamethasone vs melphalan + prednisone + thalidomide in first-line multiple myeloma
CTR20132976Phase 3Active
- Sponsor
- NewBase
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lenalidomide in multiple myeloma (MM), sponsored by NewBase. Started Feb 2014; status: active.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on CTR20132976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132976.